DAVIS, Calif.--(BUSINESS WIRE)--Sep. 15, 2015--
Arcadia Biosciences, Inc. (NASDAQ: RKDA), an agricultural technology
company that develops and commercializes plant traits and products that
improve farm economics and benefit the environment and human health,
announced that it will participate in the 6th Annual Credit
Suisse Small & Mid Cap Conference at the Waldorf Astoria Hotel in New
York City. Roger Salameh, Arcadia’s vice president of business
development, is scheduled to present at 2:30 p.m. EDT on Thursday,
September 17, 2015.
Mr. Salameh and Tom O’Neil, Arcadia’s chief financial officer, will be
available for one-on-one meetings with investors throughout the day.
Investors attending the conference may schedule a meeting through their
representatives at Credit Suisse.
A copy of Arcadia’s latest investor presentation will be provided at the
conference and also will be made available in the Investors section of
the company’s website.
About Arcadia Biosciences, Inc.
Based in Davis, Calif., with additional facilities in Seattle, Wash. and
Phoenix, Ariz., Arcadia Biosciences (NASDAQ: RKDA) develops agricultural
products that create added value for farmers while benefitting the
environment and enhancing human health. Arcadia’s agronomic performance
traits, including Nitrogen Use Efficiency, Water Use Efficiency,
Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all
aimed at making agricultural production more economically efficient and
environmentally sound. Arcadia’s nutrition traits and products are aimed
at creating healthier ingredients and whole foods with lower production
costs. The company was recently listed in the Global Cleantech 100 and
was previously named one of MIT Technology Review's 50 Smartest
Companies. For more information, visit www.arcadiabio.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915006487/en/
Source: Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc.
Jeff Bergau, +1-312-217-0419